Ticker > Company >

Tavexia Lifecare share price

Tavexia Lifecare Ltd.

  20.07 K   16   3 BSE: 539519 SECTOR: Trading

1.16
+0.01 (0.87%)
BSE: 30 Oct 4:00 PM

Price Summary

Today's High

₹ 1.18

Today's Low

₹ 1.15

52 Week High

₹ 1.25

52 Week Low

₹ 0.49

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 44.5 Cr.

Enterprise Value

₹ 45 Cr.

No. of Shares

38.36 Cr.

P/E

0

P/B

1.05

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1.1

CASH

₹ 0.01 Cr.

DEBT

₹ 0.52 Cr.

Promoter Holding

3.65 %

EPS (TTM)

₹  -0.02

Sales Growth

48.12%

ROE

10.94 %

ROCE

13.85%

Profit Growth

108.94 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year48.12%
3 Year50.63%
5 Year65.36%

Profit Growth

1 Year108.94%
3 Year399.35%
5 Year333.04%

ROE%

1 Year10.94%
3 Year8.19%
5 Year7.59%

ROCE %

1 Year13.85%
3 Year10.46%
5 Year10.14%

Debt/Equity

0.0216

Price to Cash Flow

84.56

Interest Cover Ratio

63.8777

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2026 3.65 0.00
Jun 2026 6.39 0.00
Mar 2026 6.39 0.00
Dec 2025 6.40 0.00
Sep 2025 6.40 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 50.62686504968% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 63.8777.
  • The Company has been maintaining an effective average operating margins of 43.58094% in the last 5 years.
  • Company’s PEG ratio is 0.670960606317948.
  • Company has a healthy liquidity position with current ratio of 6.4181.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 8.38729907165244.

 Limitations

  • Company has high debtor days of 365.1768.
  • Promoter stake has been decreased from 6.39% to 3.65%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 1.22 1.96 0.73 0.32 0.23
Total Expenditure 0.44 1.01 1.28 0.9 0.42
Operating Profit 0.78 0.95 -0.55 -0.58 -0.18
Other Income 0 0 0 0.02 0
Interest 0.01 0.01 0.01 0.01 0.05
Depreciation 0.08 0.13 0.16 0.18 0.14
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.69 0.81 -0.72 -0.76 -0.37
Tax 0.04 0.21 -0.01 -0.19 -0.15
Profit After Tax 0.65 0.6 -0.71 -0.57 -0.22
Adjusted EPS (Rs) 0.03 0.02 -0.02 -0.01 -0.01

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 1.29 1.54 2.19 3.55 5.26
Total Expenditure 0.68 1.43 1.17 1.6 2
Operating Profit 0.61 0.11 1.01 1.95 3.26
Other Income 0 0.03 0.1 0.02 0.4
Interest 0 0.06 0.09 0.05 0.05
Depreciation 0.02 0.06 0.22 0.38 0.42
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.6 0.03 0.8 1.53 3.19
Tax 0.16 0.01 0.24 0.34 0.7
Net Profit 0.44 0.02 0.56 1.19 2.49
Adjusted EPS (Rs.) 0.07 0 0.04 0.05 0.11

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 3.2 3.2 8 12 19.2
Total Reserves 0.44 0.46 7.44 10.15 4.72
Borrowings 0 0 0 0 0.42
Other N/C liabilities 0 0 0.03 -0.02 -0.15
Current liabilities 0.61 0.7 0.84 1.09 2.24
Total Liabilities 4.25 4.36 16.31 23.22 26.43
Assets
Net Block 0.1 0.15 1.51 1.13 1.15
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0.03 8.13 10.89 10.89
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 4.15 4.18 6.68 11.2 14.39
Total Assets 4.25 4.36 16.31 23.22 26.43
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0.6 0.02 0.77 1.53 3.19
Adjustment 0.01 0.08 0.22 0.4 -0.21
Changes in Assets & Liabilities -1.2 -0.12 -2.31 -4.36 -1.75
Tax Paid 0 -0.01 -0.21 -0.34 -0.7
Operating Cash Flow -0.59 -0.03 -1.52 -2.77 0.53
Investing Cash Flow -0.08 -0.15 -9.68 -2.77 -0.48
Financing Cash Flow 0.87 -0.02 11.22 5.51 -0.05
Net Cash Flow 0.2 -0.2 0.02 -0.03 0

Corporate Actions

Investors Details

PARTICULARS Sep 2025% Dec 2025% Mar 2026% Jun 2026% Sep 2026%
promoters 6.40 6.40 6.39 6.39 3.65
puja agarwal . 0.01 0.01 0.02 0.02 0.02
roshan dealmark private l... 6.39 6.39 6.37 6.37 3.63
PARTICULARS Sep 2025% Dec 2025% Mar 2026% Jun 2026% Sep 2026%
investors 93.60 93.60 93.61 93.61 96.35
anil gokulchand gupta - - 1.15 1.15 1.15
arya fin-trade services i... 2.29 1.30 2.14 2.16 2.20
bhansali value creations ... - - - 1.38 1.53
bimladevi toshniwal 1.04 1.04 1.04 1.04 1.04
comfort capital private l... 5.37 4.28 6.03 6.24 6.24
kamal asnani 1.93 - 1.58 1.58 1.89
khushboo . . - - - - 1.78
krishna kumar goyal 1.45 1.42 2.20 6.17 6.95
l7 hitech private limited... - 3.98 6.68 6.68 5.81
maheshkumar subhashkumar ... - - 1.30 1.30 1.30
manju devi - - 1.12 1.60 1.83
meeta tejas shah . - 1.45 1.45 1.45 1.45
mohit mahesh mehta - - 1.06 1.27 1.44
nikhil amritlal rajawat 1.48 1.48 1.48 1.48 1.48
parasrampuria infrastruct... - - 1.52 2.41 2.41
sunny kumar . - - - - 6.36
rajeev . . - - 2.47 6.32 -
aarshi manish mehta 1.78 1.12 1.12 - -
jemishkumar odhavjibhai g... 1.05 1.05 1.05 - -
kanabar parag suresh 2.50 2.50 2.50 - -
omjay . jani 2.86 1.94 1.94 - -
balgopal commercial limit... 1.76 1.76 - - -
jaiprakash agarwal 1.09 1.09 - - -
maheshkumar subhashkumar ... - 1.30 - - -
parag sunil agrawal huf - 1.55 - - -
rahul goyal huf . 2.09 2.09 - - -
sunita j agarwal - 2.43 - - -
comfort securities limite... 2.61 - - - -
globalworth securities li... 1.44 - - - -
maheshkumar subhashkumar ... 1.30 - - - -
randeep singh 4.68 - - - -
sunita agarwal 2.02 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Tavexia Lifecare rises on getting nod to acquire 60% stake in Meyonex Pharmaceuticals 13 Oct, 10:50 AM Tavexia Lifecare gets nod to acquire 60% stake in Meyonex Pharmaceuticals 13 Oct, 10:39 AM Tavexia Lifecare informs about disclosure 24 Sep, 11:10 AM Tavexia Lifecare informs about disclosure on SAST 16 Sep, 12:33 PM Tavexia Lifecare informs about disclosures 7 Sep, 1:07 PM Tavexia Lifecare shines on expanding into pharmaceutical business 26 Aug, 2:51 PM Tavexia Lifecare expands into pharmaceutical business 26 Aug, 2:29 PM Sattva SukunLifecare - Quaterly Results 5 Aug, 12:00 AM Sattva Sukun Lifecare informs about press release 8 Jun, 3:51 PM Sattva Sukun Lifecare submits board meeting intimation 25 May, 3:59 PM Sattva Sukun Lifecare informs about compliances-certificate 8 Apr, 4:57 PM Sattva Sukun Lifecare informs about newspaper publication 23 Feb, 5:24 PM Sattva Sukun Lifecare informs about delay in financial results 5 Dec, 4:54 PM Sattva Sukun Lifecare informs about newspaper clipping 27 Nov, 4:57 PM Sattva Sukun Lifecare informs about closure of trading window 29 Sep, 2:40 PM Sattva Sukun Lifecare acquires 51% paid up share capital of M/s Pavapuri Export 11 Sep, 11:43 AM Sattva Sukun Lifecare informs about newspaper publication 10 Sep, 2:30 PM Sattva Sukun Lifecare informs about AGM 8 Sep, 5:05 PM Sattva Sukun Lifecar - Quaterly Results 12 Aug, 7:31 PM Sattva Sukun Lifecar - Quaterly Results 12 Aug, 7:31 PM Sattva Sukun Lifecare gets nod to establish manufacturing unit in Firozabad 26 May, 12:45 PM Sattva Sukun Lifecar - Quaterly Results 5 May, 2:29 PM Sattva Sukun Lifecar - Quaterly Results 5 May, 2:29 PM Sattva Sukun Lifecar - Quaterly Results 5 May, 2:29 PM Sattva Sukun Lifecare bags purchase order from Mansi Kreation 23 Apr, 11:52 AM Sattva Sukun Lifecare bags purchase order from Mangalam Brands 3 Apr, 3:00 PM Sattva Sukun Lifecare informs about disclosure 3 Apr, 1:53 PM Sattva Sukun Lifecar - Quaterly Results 11 Feb, 5:48 PM Sattva Sukun Lifecar - Quaterly Results 11 Feb, 5:48 PM Mayukh Dealtrade receives purchase order from Mangalam Brands 7 Jan, 4:26 PM Mayukh Dealtrade informs about newspaper publication 7 Dec, 4:34 PM Mayukh Dealtrade completes order receive from Unique Gifts for Alkem Laboratories 15 Nov, 5:20 PM Mayukh Dealtrade informs about certificate 8 Oct, 4:51 PM Mayukh Dealtrade informs about board meeting 24 Aug, 3:09 PM Mayukh Dealtrade informs about outcome of bard meeting 17 Aug, 3:39 PM Mayukh Dealtrade - Quaterly Results 5 Aug, 6:45 PM Mayukh Dealtrade - Quaterly Results 5 Aug, 6:45 PM Mayukh Dealtrade - Quaterly Results 5 Aug, 6:45 PM Mayukh Dealtrade informs about outcome of preferential allotment committee meet 27 Jan, 12:50 PM Mayukh Dealtrade - Quaterly Results 19 Jan, 6:22 PM Mayukh Dealtrade - Quaterly Results 19 Jan, 6:22 PM Mayukh Dealtrade - Quaterly Results 19 Jan, 6:22 PM Mayukh Dealtrade informs about press release 21 Nov, 4:27 PM Mayukh Dealtrade - Quaterly Results 10 Aug, 5:28 PM Mayukh Dealtrade - Quaterly Results 22 May, 6:37 PM Mayukh Dealtrade - Quaterly Results 22 May, 6:37 PM Mayukh Dealtrade informs about newspaper publication 24 Jan, 5:07 PM Mayukh Dealtrade - Quaterly Results 23 Jan, 3:14 PM Mayukh Dealtrade - Quaterly Results 23 Jan, 3:14 PM Mayukh Dealtrade informs about rescheduling of board meeting 24 Dec, 3:28 PM

Tavexia Lifecare Stock Price Analysis and Quick Research Report. Is Tavexia Lifecare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Tavexia Lifecare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Tavexia Lifecare has a PE ratio of -49.5726495726496 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Tavexia Lifecare has ROA of 10.0324% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Tavexia Lifecare has a Current ratio of 6.4181.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Tavexia Lifecare has a ROE of 10.9401%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Tavexia Lifecare has a Debt to Equity ratio of 0.0216 which means that the company has low proportion of debt in its capital.

  • Sales growth: Tavexia Lifecare has reported revenue growth of 48.1158% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Tavexia Lifecare for the current financial year is 61.9171575147254%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Tavexia Lifecare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Tavexia Lifecare is Rs -0.0234. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Tavexia Lifecare in Ticker for free. Also, one can get the intrinsic value of Tavexia Lifecare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Tavexia Lifecare FAQs

Q1. What is Tavexia Lifecare share price today?
Ans: The current share price of Tavexia Lifecare is Rs 1.16.

Q2. What is the market capitalisation of Tavexia Lifecare?
Ans: Tavexia Lifecare has a market capitalisation of Rs 44.497744768 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Tavexia Lifecare?
Ans: The PE ratio of Tavexia Lifecare is -49.5726495726496 and the P/B ratio of Tavexia Lifecare is 1.05444959549132, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Tavexia Lifecare share?
Ans: The 52-week high share price of Tavexia Lifecare is Rs 1.25, and the 52-week low share price of Tavexia Lifecare is Rs 0.49.

Q5. Does Tavexia Lifecare pay dividends?
Ans: Currently, Tavexia Lifecare does not pay dividends. Dividend yield of Tavexia Lifecare is around 0%.

Q6. What are the face value and book value of Tavexia Lifecare shares?
Ans: The face value of Tavexia Lifecare shares is Rs 1, while the book value per share of Tavexia Lifecare is around Rs 1.1001. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Tavexia Lifecare?
Ans: Tavexia Lifecare has a total debt of Rs 0.5172 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Tavexia Lifecare?
Ans: The ROE of Tavexia Lifecare is 10.9401% and ROCE of Tavexia Lifecare is 13.8517%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Tavexia Lifecare a good buy for the long term?
Ans: The Tavexia Lifecare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Tavexia Lifecare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Tavexia Lifecare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Tavexia Lifecare’s financials?
Ans: You can review Tavexia Lifecare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Tavexia Lifecare
X